ILARIS

Google image searchProduct monograph

Active ingredient

canakinumab, 150 MG/ML

DIN: 02460351

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 22-AUG-2017

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AC — Interleukin inhibitors (ATC, ATC/DDD)
• L04AC08 — CANAKINUMAB (ATC/DDD)

Reference brand drug: Ilaris

External Links for Ilaris

Search on Google

• Ilaris side effects
• Ilaris dosage
• canakinumab side effects
• canakinumab dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find ilaris photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.